Evidence map›Paper›PMID 38337210›Full record

ArticlePolymers2024

Crystallization of Polylactic Acid with Organic Nucleating Agents under Quiescent Conditions.

Peng Gao, Saeed Alanazi, Davide Masato

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Peng GaoDepartment of Plastics Engineering, University of Massachusetts Lowell, Lowell, MA 01854, USA.
Saeed AlanaziDepartment of Plastics Engineering, University of Massachusetts Lowell, Lowell, MA 01854, USA.
Davide MasatoDepartment of Plastics Engineering, University of Massachusetts Lowell, Lowell, MA 01854, USA.ORCID 0000-0002-9640-8179
University of Massachusetts Lowell · US

Funding

University of Massachusetts Lowell Provost Office Start-Up fundsWestern Washington University 12563Western Washington University MS0149
6 · The paper itself

Abstract

Polylactic acid (PLA) is a versatile and sustainable polymer used in various applications. This research explores the use of orotic acid (OA) and ethylene bis-stearamide (EBS) as nucleating agents to enhance the quiescent crystallization of PLA within the temperature range of 80 °C to 140 °C. Different blends were produced via melt processing before analyzing via DSC, XRD, and SEM. Our results show that both nucleating agents significantly accelerated the crystallization process and reduced the incubation time and the crystallization half-time. The most promising results were obtained with 1% EBS at 110 °C, achieving the fastest crystallization. The XRD analysis showed that at 80 °C, the disordered α'phase predominated, while more stable α phases formed at 110 °C and 140 °C. Combining the 1% nucleating agent and 110 °C promotes densely packed crystalline lamellae. The nucleated PLA exhibited a well-organized spherulitic morphology in agreement with the Avrami modeling of DSC data. Higher nucleating agent concentrations yielded smaller, more evenly distributed crystalline domains. Utilizing OA or EBS in PLA processing could offer enhanced properties, improved processability, and cost-efficiency, making PLA more competitive in various applications.

Indexed as

crystallization behaviordifferential scanning calorimetryorganic nucleating agentpolylactic acid (PLA)quiescent conditions

Identifiers

PMID38337210
PMCPMC10857276
OpenAlexW4391167634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.